{"id":"low-severity-group-escitalopram","safety":{"commonSideEffects":[{"rate":"15-20","effect":"Nausea"},{"rate":"10-15","effect":"Headache"},{"rate":"10-15","effect":"Insomnia"},{"rate":"5-10","effect":"Somnolence"},{"rate":"10-15","effect":"Sexual dysfunction"},{"rate":"5-10","effect":"Diarrhea"},{"rate":"5-10","effect":"Dry mouth"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Escitalopram is the active S-enantiomer of citalopram and works as a selective serotonin reuptake inhibitor (SSRI). By blocking the serotonin transporter protein, it prevents the reabsorption of serotonin from the synaptic cleft back into the presynaptic neuron, thereby prolonging serotonin's effects on postsynaptic receptors. This increased serotonergic neurotransmission is thought to improve mood and reduce anxiety symptoms.","oneSentence":"Escitalopram selectively inhibits the reuptake of serotonin at the neuronal synapse, increasing serotonin availability in the brain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:36:53.987Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"},{"name":"Generalized anxiety disorder"}]},"trialDetails":[{"nctId":"NCT01324700","phase":"PHASE4","title":"Antidepressant Treatment at an Inner City Asthma Clinic","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2010-07","conditions":"Depression, Asthma","enrollment":139}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Lexapro, Selective serotonin reuptake inhibitor (SSRI)"],"phase":"marketed","status":"active","brandName":"Low severity group: Escitalopram","genericName":"Low severity group: Escitalopram","companyName":"University of Texas Southwestern Medical Center","companyId":"university-of-texas-southwestern-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Escitalopram selectively inhibits the reuptake of serotonin at the neuronal synapse, increasing serotonin availability in the brain. Used for Major depressive disorder, Generalized anxiety disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}